Ferney-Voltaire, France

Michael J Harper

This inventor holds 1 USPTO granted patent. Top assignee: Imperial Chemical Industries Limited. Active years: 1985.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael J Harper. Retrieved from https://idiyas.com/inventor/michael-j-harper

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 48(Granted Patents)


Company Filing History:


Years Active: 1985

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Michael J Harper

Introduction

Michael J Harper is a notable inventor based in Ferney-Voltaire, France. He has made significant contributions to the field of chemistry, particularly in the development of alkene derivatives. His work has implications in the medical field, especially concerning anti-oestrogens.

Latest Patents

Harper holds a patent for alkene derivatives, specifically for a compound known as 1-(p-.beta.-dimethylaminoethyoxyphenyl)-1,2-diphenylbut-1-ene. This compound is recognized for its utility as an anti-oestrogen, showcasing Harper's innovative approach to chemical applications.

Career Highlights

Throughout his career, Michael J Harper has been associated with Imperial Chemical Industries Limited, a prominent company in the chemical industry. His work there has allowed him to explore various chemical innovations and contribute to advancements in the field.

Collaborations

Some of his notable coworkers include Dora N Richardson and Arthur L Walpole, who have also made significant contributions to their respective fields.

Conclusion

Michael J Harper's work in the field of alkene derivatives highlights his innovative spirit and dedication to advancing chemical research. His contributions continue to influence the development of important medical applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…